2023: Echopoint Medical starts its first in human study at Barts Heart Centre (London, UK). This milestone was recognised by the Financial Times and with coverage by Clive Cookson.
2022: Echopoint Medical obtain regulatory approval for a First-in-Human study in the United Kingdom from the Medicines and Healthcare products Regulatory Agency (MHRA)
2022: Malcolm Finlay Presents at the Innovators Competition at EuroPCR (Paris)
2022: Antony Odell presents at the Innovation Summit (Dublin)
2022: Antony pitches at the LSX World Congress (London)
2021: Adrien Desjardins awarded a Royal Society Fellowship spanning Echopoint and the University College London
2021: Malcolm presents at ICI: Innovation in Cardiovascular Intervention (Tel Aviv)
2021: Echopoint Medical receives ISO 13845 Certification
2020: Echopoint are awarded a Smart Grant from Innovate UK
2019: Malcolm presents at ICI: Innovation in Cardiovascular Intervention (Tel Aviv)
2019: Echopoint Medical are awarded a Precision Medicine Award from Innovate UK
2019: Echopoint Medical are awarded a Biomedical Catalyst Award
2019: Echopoint Medical wins at the 2019 SEHTA MedTech Business Award
2019: Echopoint Medical win the UCL Business Innovators Award